| Management target | Revenue 18.6% FY27 |
|---|
| Revenue growth | 31.34% YoY in Q1 FY27. |
|---|---|
| Margins | EBITDA margin at 28.1%; full-year target stabilized at 20%. |
| Demand visibility | Steady orders across domestic markets; expanding IP-grade pharma base. |
| Management confidence | High on long-term sustainable growth and Kronox integration synergies. |
Growth
Revenue rose 31.34% to ₹70.36 Cr; EBITDA up 62.16% to ₹19.8 Cr; PAT increased 59.31% to ₹16.25 Cr.
Outlook
FY27 guidance: ₹250-260 Cr revenue with 20% EBITDA margin. Planned ₹50 Cr capex for Boron Oxide/Boric Acid expansion.
Risks
Q2 seasonality (monsoon), volatile raw material costs due to war, and potential margin compression vs Q1 peaks.
Last quarter's promises, checked
Delivered
- Guided FY26 Revenue ~₹215 Cr → delivered ₹215.45 Cr (= BEAT)
- Guided DOT sales 1,500 tons → delivered ~1,500 tons target track (= BEAT)
- Guided 20-21% EBITDA margin → delivered 28.1% in Q1 FY27 (= BEAT)
Partly delivered
- Guided Boron Oxide launch in 3-4 quarters → In progress/Capex stage (= PARTIAL)
Earnings Call Transcript filed with NSE, NSE: INDOBORAX. Summary written with AI assistance from the document.
Indo Borax & Chemicals Ltd: key numbers
- Share price
- ₹383.75
- Market cap
- ₹1,231 Cr
- Revenue (annual)
- ₹215.4 Cr
- Net profit (annual)
- ₹50.27 Cr
- P/E (TTM)
- 27.5×Sector 35.5×
- Promoter holding
- 38.41%+0.00% QoQ
- FII holding
- 0.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indo Borax & Chemicals Ltd
All →Indo Borax & Chemicals Q2 FY27 Results: Net Profit ₹4.7 Cr, Down 71.2% YoY
Indo Borax & Chemicals Ltd reported revenue from operations of ₹58.9 Cr (+1.9% YoY) and net profit of ₹4.7 Cr (-71.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹4.7 Cr · -71.2% YoY
Indo Borax & Chemicals Debt & Borrowing: ₹225 Cr
Indo Borax pledged 14% of Kronox Lab Sciences shares as security for a ₹225 crore term loan. Kronox remains its subsidiary.
- Value
- ₹225.0 Cr
Indo Borax & Chemicals Board Meeting Date
Indo Borax & Chemicals will hold a board meeting on 6 November 2026 to approve unaudited standalone and consolidated results for the quarter and half-year ended 30 September 2026. Trading window remains closed until 48 hours after results.
Indo Borax & Chemicals Order Update
Indo Borax & Chemicals amended its Share Purchase Agreement dated August 20, 2026, by removing lock-in restrictions and the right of first refusal. This amendment clarifies promoter status.
Indo Borax & Chemicals Other Announcement
Indo Borax & Chemicals Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Indo Borax & Chemicals Debt & Borrowing: ₹225 Cr
Indo Borax created a pledge over 14% of subsidiary Kronox's shares to secure a ₹225 crore term loan. The pledge does not alter the company's control of the subsidiary.
- Value
- ₹225.0 Cr